Stocks Screener

Specify Company / Ticker to Get the Summary

Internet ComputerICP
Bitcoin CashBCH
LitecoinLTC
Field stub for analysis

Venture Life Group PLC

17V
Current price
0.42 EUR +0.01 EUR (+2.44%)
Last closed36.50 GBX
ISIN GB00BFPM8908
SectorConsumer Defensive
IndustryHousehold & Personal Products
ExchangeFrankfurt Exchange
Capitalization 48 616 382 GBX
Yield for 12 month +4.32 %
1Y
3Y
5Y
10Y
15Y
17V
21.11.2021 - 28.11.2021

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ brand. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos, as well as Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; Baby Earol, an ear spray for babies; and Sterinase for relieving blocked noses, clearing nasal passages, and preventing the risk of allergic reactions and infections. It also provides oncology support products, such as Pomi-T, used for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid based topical gel, for the prevention and treatment of Radiation Induced Dermatitis. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom. Address: 12 The Courtyard, Bracknell, United Kingdom, RG12 2XB

Check your investment idea

Find the best to beat the market
TSLATSLATesla Motors
AAPLAAPLApple
MSFTMSFTMicrosoft

Analytics

WallStreet Target Price

5 503.34 GBX

P/E ratio

37.25

Dividend Yield

Current Year

+5 281 080 337 GBX

Last Year

+4 517 835 242 GBX

Current Quarter

+2 409 306 736 GBX

Last Quarter

+2 871 773 601 GBX

Current Year

+2 069 904 076 GBX

Last Year

+1 814 633 006 GBX

Current Quarter

+918 564 835 GBX

Last Quarter

+1 174 041 390 GBX

Key Figures 17V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 7 934 434 GBX
Operating Margin TTM -0.21 %
PE Ratio 37.25
Return On Assets TTM 1.56 %
PEG Ratio
Return On Equity TTM 1.00 %
Wall Street Target Price 5 503.34 GBX
Revenue TTM 52 810 803 GBX
Book Value 0.60 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 13 311 075 GBX
Earnings per share 0.010 GBX
Diluted Eps TTM 0.010 GBX
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 223.20 %
Profit Margin 1.44 %

Dividend Analytics 17V

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y>5 - expected 5-9 dividend yield on cost over 10Y<5 - expected <5 dividend yield on cost over 10YMaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History 17V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 24.05.2018
Forward Annual Dividend Yield
Last Split Factor 722:721
Payout Ratio
Last Split Date 23.11.2020
Dividend Date

Stock Valuation 17V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 37.25
Forward PE 6.07
Enterprise Value Revenue 1.22
Price Sales TTM 0.92
Enterprise Value EBITDA 6.51
Price Book MRQ 0.64

Financials 17V

1 year
3 years
5 years
10 years
15 years
Results2019Dynamics
* The data for this period has not yet been published

Technical indicators 17V

For 52 weeks

33.18 GBX 52.69 GBX
50 Day MA 42.06 GBX
Shares Short Prior Month
200 Day MA 43.58 GBX
Short Ratio
Shares Short
Short Percent